Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w.
J Indian Med Assoc
;
2003 Sep; 101(9): 559-60
Article
Dans Anglais
| IMSEAR
| ID: sea-103727
ABSTRACT
Mycobacterium w (immuvac), a new potent immunomodulator was evaluated as concomitant therapy in the management of muscle invasive bladder cancer along with external beam radiation therapy. There was no residual tumour in all the five patients after two months of therapy. All patients remained disease free for an observation period of more than 2 years.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Tumeurs de la vessie urinaire
/
Femelle
/
Humains
/
Mâle
/
Vaccins antibactériens
/
Carcinome transitionnel
/
Projets pilotes
/
Association thérapeutique
/
Adulte d'âge moyen
/
Muscles lisses
langue:
Anglais
Texte intégral:
J Indian Med Assoc
Année:
2003
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS